OXGENE Introduces SLIM Platform for Discovery of Antibodies Against Membrane Proteins – Business Wire

OXFORD, England–(BUSINESS WIRE)–OXGENE, a biotechnology company offering integrated discovery and manufacturing technologies to the cell and gene therapy industry, announces the introduction of its self-labelling integral membrane (SLIM) protein discovery system. The novel method allows for the identification of antibodies against membrane proteins in their native configuration in mammalian cells, which could catalyse the discovery of new candidates for antibody-based therapies.
In SLIM display,…

Click here to view the original article.